Obinutuzumab is Effective as an Initial Treatment for PLA2R-Associated Primary Membranous Nephropathy: A Retrospective, Single-Center Trial
Xue-Qi Li,1 Yang Liu,1 Ze-Yu Cai,1 Tie-Gang Lv,2 Jian Hao1 1Department of Medicine, Division of Nephrology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, 010050, China; 2Department of Medicine, Division of Radiology, The Affiliated Hospital o...
Saved in:
| Main Authors: | Li XQ, Liu Y, Cai ZY, Lv TG, Hao J |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/obinutuzumab-is-effective-as-an-initial-treatment-for-pla2r-associated-peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obinutuzumab for treatment of membranous nephropathy in patients positive and negative for the phospholipase A2 receptor antibody: case reports
by: Jinmeng Wang, et al.
Published: (2025-04-01) -
Obinutuzumab as Initial or Second-Line Therapy in Patients With Primary Membranous Nephropathy
by: Xiaole Su, et al.
Published: (2024-08-01) -
Role of PLA2R domain antibodies and epitope spreading in risk stratification and prediction of proteinuria remission in primary membranous nephropathy
by: Xiran Zhang, et al.
Published: (2025-02-01) -
Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies
by: Maxime Teisseyre, et al.
Published: (2025-03-01) -
Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study
by: Xi Cheng, et al.
Published: (2025-08-01)